RE: Oxford nanopore technologies2 Oct 2021 18:25
https://www.fool.co.uk/investing/2021/10/01/after-a-blockbuster-ipo-is-the-oxford-nanopore-share-price-too-expensive/
What has become so clear to me when trading small cap stocks / growth stocks is that year on year revenue increases is EVERYTHING. It sounds incredibly basic but seeing revenue rising and compounding year on year leads to the share price nearly always following suit. Other factors do of course come into it but they are less important to the small cap 'investor'.
I am absolutely convinced that the novacyt share price would be higher if they had turned over say £50m last year and now about to turn over £100m, articles would be written highlighting how revenues are continuing to grow exponentially and it becomes easy to imagine that £50m last year, £100m this year, becomes £150m+ next year and then even £250m after that. The reality isn't all that important, it's the imagination that triggers speculative buying in small caps and as long as revenue keeps rising there is nothing to stop the momentum.
Instead our tagline reads something like this: 2020 - £277m, 2021 - £100m, 2022 - ??? Well looking at those numbers £50m? 2023 £35m? We know that's not the case but that narrative is quickly and easily spun. Forget the fact that we made more profit than any other AIM company in 2020 I believe, yes even more than giants like ASOS. It's not important to traders in the short term, the trend is all that matters...
Of course this seems so basic but I've looked at hundreds of small cap stocks and this is a very, very common theme. And eventually the fundamentals DO play out, those companies seeing exponential SP rises crash when revenues dip one year/quarter and suddenly the lack of profit and fundamentals comes into focus, but sometimes that takes years to play out.